Select Medical Holdings Co. (NYSE:SEM) Chairman Robert A. Ortenzio sold 11,459 shares of the stock in a transaction on Monday, February 24th. The shares were sold at an average price of $28.17, for a total value of $322,800.03. Following the completion of the sale, the chairman now owns 6,393,036 shares of the company’s stock, valued at approximately $180,091,824.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of NYSE:SEM traded down $0.15 during midday trading on Wednesday, hitting $25.73. 1,092,500 shares of the stock were exchanged, compared to its average volume of 943,314. The company has a debt-to-equity ratio of 4.60, a quick ratio of 1.33 and a current ratio of 1.33. Select Medical Holdings Co. has a 52-week low of $12.96 and a 52-week high of $28.61. The business’s fifty day simple moving average is $24.41 and its two-hundred day simple moving average is $20.28. The company has a market capitalization of $3.69 billion, a PE ratio of 23.39, a P/E/G ratio of 1.41 and a beta of 1.33.
Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.11. Select Medical had a return on equity of 17.44% and a net margin of 2.72%. The business had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same period last year, the company earned $0.20 earnings per share. Select Medical’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities analysts anticipate that Select Medical Holdings Co. will post 1.39 EPS for the current year.
A number of analysts have recently issued reports on the company. Credit Suisse Group set a $18.00 target price on Select Medical and gave the company a “hold” rating in a report on Friday, November 1st. Royal Bank of Canada restated a “positive” rating and issued a $32.00 target price on shares of Select Medical in a report on Monday. ValuEngine lowered Select Medical from a “hold” rating to a “sell” rating in a report on Tuesday, January 7th. Finally, Deutsche Bank increased their target price on Select Medical from $22.00 to $33.00 and gave the company a “buy” rating in a report on Monday. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $23.40.
About Select Medical
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Further Reading: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.